Simultaneous display of two large proteins on the head and tail of bacteriophage lambda

BMC Biotechnology

Volumn 13, Issue , 2013, Pages

  Pavoni, Emiliano ^a   Vaccaro, Paola ^a   D'Alessio, Valeria ^a   De Santis, Rita ^a   Minenkova, Olga ^a  

^a Sigma Tau SpA   (Italy)

Author keywords

CEA; Lambda display; Nanoparticles; Tumor targeting

Indexed keywords

ALKALINE PHOSPHATASE; CEA; FILAMENTOUS PHAGE DISPLAY; FUNCTIONAL MOIETIES; GREEN FLUORESCENT PROTEIN; SINGLE-CHAIN ANTIBODIES; TARGETED NANOPARTICLE; TUMOR TARGETING;

CHEMICAL DETECTION; DIAGNOSIS; DISPLAY DEVICES; NANOPARTICLES; PEPTIDES; PHOSPHATASES;

BACTERIOPHAGES;

ALKALINE PHOSPHATASE; GPD PROTEIN; GPV PROTEIN; GREEN FLUORESCENT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BACTERIOPHAGE LAMBDA; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHAGE DISPLAY; PROTEIN ENGINEERING; PROTEIN EXPRESSION;

ALKALINE PHOSPHATASE; ANIMALS; BACTERIOPHAGE LAMBDA; CAPSID PROTEINS; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ESCHERICHIA COLI; GENETIC VECTORS; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; HT29 CELLS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NANOPARTICLES; PEPTIDE LIBRARY; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 84884956600     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-13-79     Document Type: Article

References (39)

1. Twort FW. An investigation on the nature of ultra-microscopic viruses. Lancet 1915, 186:1241-1243.
2. D'Herelle F. Sur un microbe invisible antagoniste des bacteries dysentèriques. Compt Rend Acad Sci Paris 1917, 165:373-375.
3. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317. 10.1126/science.4001944, 4001944.
4. Iannolo G, Minenkova O, Petruzzelli R, Cesareni G. Modifying filamentous phage capsid: limits in the size of the major capsid protein. J Mol Biol 1995, 248:835-844. 10.1006/jmbi.1995.0264, 7752244.
5. Model P, Russel M. Filamentous Bacteriophage. The bacteriophages 1988, 375-456. New York: Plenum Press, Calendar R.
6. Kay BK, Adey NB, He YS, Manfredi JP, Mataragnon AH, Fowlkes DM. An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene 1993, 128:59-65. 10.1016/0378-1119(93)90153-T, 8508960.
7. Peters EA, Schatz PJ, Johnson SS, Dower WJ. Membrane insertion defects caused by positive charges in the early mature region of protein pIII of filamentous phage fd can be corrected by prlA suppressors. J Bacteriol 1994, 176:4296-4305. 205641, 8021215.
8. Iannolo G, Minenkova O, Gonfloni S, Castagnoli L, Cesareni G. Construction, exploitation and evolution of a new peptide library displayed at high density by fusion to the major coat protein of filamentous phage. Biol Chem 1997, 378:517-521.
9. Minenkova O, Gargano N, Vaccaro P, Garufi G, Felici F. Bacteriophage lambda surface display: recent results open wide application perspectives. Chapter 5 in Frontiers in DNA Research 2006, 81-113. New York: Nova Science Publishers, inc, Woods CR.
10. Vaccaro P, Pavoni E, Monteriù G, Pucci A, Felici F, Minenkova O. Efficient display of scFv antibodies on bacteriophage lambda. J Immunol Methods 2006, 310:149-158. 10.1016/j.jim.2006.01.003, 16497320.
11. Stolz J, Ludwig A, Sauer N. Bacteriophage lambda surface display of a bacterial biotin acceptor domain reveals the minimal peptide size required for biotinylation. FEBS Lett 1998, 440:213-217. 10.1016/S0014-5793(98)01454-9, 9862457.
12. Stolz J, Ludwig A, Stadler R, Biesgen C, Hagemann K, Sauer N. Structural analysis of a plant sucrose carrier using monoclonal antibodies and bacteriophage lambda surface display. FEBS Lett 1999, 453:375-379. 10.1016/S0014-5793(99)00756-5, 10405179.
13. Kuwabara I, Maruyama H, Kamisue S, Shima M, Yoshioka A, Maruyama IN. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia a patients. J Immunol Methods 1999, 224:89-99. 10.1016/S0022-1759(99)00012-5, 10357210.
14. Moriki T, Kuwabara I, Liu T, Maruyama IN. Protein domain mapping by lambda phage display: the minimal lactose-binding domain of galectin-3. Biochem Biophys Res Commun 1999, 265:291-296. 10.1006/bbrc.1999.1666, 10558859.
15. Santini C, Brennan D, Mennuni C, Hoess R, Nicosia A, Cortese R, Luzzago A. Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J Mol Biol 1998, 282:125-135. 10.1006/jmbi.1998.1986, 9733645.
16. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 2003, 106:534-544. 10.1002/ijc.11269, 12845649.
17. Pavoni E, Vaccaro P, Pucci A, Monteriù G, Beghetto E, Barca S, Dupuis ML, De Pasquale Ceratti A, Lugini A, Cianfriglia M, Cortesi E, Felici F, Minenkova O. Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage. BMC Cancer 2004, 4:78. 10.1186/1471-2407-4-78, 539249, 15541172.
18. Pavoni E, Pucci A, Vaccaro P, Monteriù G, Ceratti Ade P, Lugini A, Virdis RA, Cortesi E, De Gaetano A, Panunzi S, Felici F, Minenkova O. A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display. Cancer Detect Prev 2006, 30:248-256. 10.1016/j.cdp.2006.05.004, 16876336.
19. Gamage LN, Ellis J, Hayes S. Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes. Vaccine 2009, 27:6595-6604. 10.1016/j.vaccine.2009.08.019, 19712770.
20. Zanghi CN, Sapinoro R, Bradel-Tretheway B, Dewhurst S. A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery. Nucleic Acids Res 2007, 35:e59. 10.1093/nar/gkm146, 1885665, 17392341.
21. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CM, Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol 2007, 102:1337-1349. 10.1111/j.1365-2672.2006.03182.x, 2063594, 17448169.
22. Pope AR, Embleton M, Mernaugh R. Construction and use of antibody gene repertoires. Antibody Engineering - A practical approach 1996, 1-40. Oxford: Oxford University Press, McCafferty J, Hoogenboom H, Chiswell D.
23. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual 1982, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
24. Yang F, Forrer P, Dauter Z, Conway JF, Cheng N, Cerritelli ME, Steven AC, Pluckthun A, Wlodawer A. Novel fold and capsid-binding properties of the lambda-phage display platform protein gpD. Nat Struct Biol 2000, 7:230-237. 10.1038/73347, 10700283.
25. Sternberg N, Hoess RH. Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci U S A 1995, 92:1609-1613. 10.1073/pnas.92.5.1609, 42569, 7878027.
26. Mikawa YG, Maruyama IN, Brenner S. Surface display of proteins on bacteriophage lambda heads. J Mol Biol 1996, 262:21-30. 10.1006/jmbi.1996.0495, 8809176.
27. Niwa M, Maruyama H, Fujimoto T, Dohi K, Maruyama IN. Affinity selection of cDNA libraries by lambda phage surface display. Gene 2000, 256:229-236. 10.1016/S0378-1119(00)00348-6, 11054552.
28. Santi E, Capone S, Mennuni C, Lahm A, Tramontano A, Luzzago A, Nicosia A. Bacteriophage lambda display of complex cDNA libraries: a new approach to functional genomics. J Mol Biol 2000, 296:497-508. 10.1006/jmbi.1999.3471, 10669604.
29. Zucconi A, Dente L, Santonico E, Castagnoli L, Cesareni G. Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of Synaptojanin 1. J Mol Biol 2001, 307:1329-1339. 10.1006/jmbi.2001.4572, 11292345.
30. Maruyama IN, Maruyama HI, Brenner S. Lambda foo: a lambda phage vector for the expression of foreign proteins. Proc Natl Acad Sci USA 1994, 91:8273-8277. 10.1073/pnas.91.17.8273, 44588, 8058794.
31. Ghaemi A, Soleimanjahi H, Gill P, Hassan Z, Jahromi SR, Roohvand F. Recombinant lambda-phage nanobioparticles for tumor therapy in mice models. Genet Vaccines Ther 2010, 8:3. 10.1186/1479-0556-8-3, 2890663, 20459865.
32. Clark JR, Bartley K, Jepson CD, Craik V, March JB. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. FEMS Immunol Med Microbiol 2011, 61(2):197-204. 10.1111/j.1574-695X.2010.00763.x, 21204995.
33. Light J, Lerner RA. Phophabs: Antibody-phage-alkaline phosphatase conjugates for one step ELISA's without immunization. Bioorg Med Chem Lett 1992, 2:1073-1078.
34. Bonnycastle LL, Brown KL, Tang J, Scott JK. Assaying phage-borne peptides by phage capture on fibrinogen or streptavidin. Biol Chem 1997, 378:509-515.
35. Gao C, Mao S, Lo CH, Wirsching P, Lerner RA, Janda KD. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays. Proc Natl Acad Sci USA 1999, 96:6025-6030. 10.1073/pnas.96.11.6025, 26829, 10339535.
36. Chen L, Zurita AJ, Ardelt PU, Giordano RJ, Arap W, Pasqualini R. Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol 2004, 11:1081-1091. 10.1016/j.chembiol.2004.05.019, 15324809.
37. Dunn IS. In vitro α-complementation of β-galactosidase on a bacteriophage surface. Eur J Biopham. 1996, 242:720-726.
38. Clark JR, March JB. Bacterial viruses as human vaccines?. Expert Rev Vaccines 2004, 3:463-476. 10.1586/14760584.3.4.463, 15270651.
39. Bearden CM, Agarwal A, Book BK, Vieira CA, Sidner RA, Ochs HD, Young M, Pescovitz MD. Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant 2005, 5:50-57. 10.1111/j.1600-6143.2003.00646.x, 15636611.